Vancocin HCl Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Vancocin HCl
V
- valdecoxib
- Valergen (estradiol)
- Valertest No 1 (estradiol / testosterone)
- Vantin (cefpodoxime)
- Vaxchora (cholera vaccine, live)
- vecuronium
- Veklury (remdesivir)
- Velivet (desogestrel / ethinyl estradiol)
- Velosef (cephradine)
- Vemlidy (tenofovir alafenamide)
- Venoglobulin-S 10% (immune globulin intravenous)
- Venoglobulin-S 5% (immune globulin intravenous)
- VeraRing (ethinyl estradiol / etonogestrel)
- Vestura (drospirenone / ethinyl estradiol)
- Vibativ (telavancin)
- Vicoprofen (hydrocodone / ibuprofen)
- Vienva (ethinyl estradiol / levonorgestrel)
- Vimovo (esomeprazole / naproxen)
- Viorele (desogestrel / ethinyl estradiol)
- Vioxx (rofecoxib)
- Viread (tenofovir)
- Visbiome Extra Strength (bifidobacterium infantis / lactobacillus acidophilus)
- Visipaque (iodixanol)
- Vistide (cidofovir)
- Vivelle (estradiol)
- Vivelle-Dot (estradiol)
- Vivlodex (meloxicam)
- Vivotif (typhoid vaccine, live)
- voclosporin
- Volnea (desogestrel / ethinyl estradiol)
- Voltaren (diclofenac)
- Voltaren-XR (diclofenac)
- Vowst (fecal microbiota spores, live)
- VP-GSTN (cholecalciferol / genistein / zinc glycinate)
- VSL#3 (bifidobacterium infantis / lactobacillus acidophilus / streptococcus thermophilus)
- VSL#3 DS (bifidobacterium infantis / lactobacillus acidophilus / streptococcus thermophilus)
- VSL#3 Junior (bifidobacterium infantis / lactobacillus acidophilus / streptococcus thermophilus)
- Vumerity (diroximel fumarate)
- Vyfemla (ethinyl estradiol / norethindrone)
- VyLibra (ethinyl estradiol / norgestimate)
More about Vancocin HCl (vancomycin)
- Vancocin HCl consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Latest FDA alerts (6)
- Side effects
- Dosage information
- During pregnancy
- Drug class: glycopeptide antibiotics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.